1 / 5

R&I: Global Orphan Drugs Market - Analysis, Research, Report

TechNavio's analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market. Detailed report at: http://www.reportsandintelligence.com/global-orphan-drugs-2014-2018-market

JamesLawrence111
Télécharger la présentation

R&I: Global Orphan Drugs Market - Analysis, Research, Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Orphan Drugs Market 2014-2018 Published on: Jan 2014 No. of Pages: 66 Reports and Intelligence

  2. Description TechNavio'sanalysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market. TechNavio's report, the Global Orphan Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Orphan Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors dominating this space are Novartis AG, F. Hoffmann-La Roche Ltd., Celgene Corp., Pfizer Inc., and Sanofi S.A.Other vendors mentioned in the report are Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Biogen Idec Inc., Bristol-Myers-Squibb Co., GlaxoSmithKline plc, Eli Lilly & Co., Merck KGaA, Novo Nordisk A/S, Onyx Pharmaceuticals Inc., Shire plc, and Vertex Pharmaceuticals Inc.

  3. Table Of Content Executive Summary List of Abbreviations Scope of the Report Market Research Methodology Market Landscape Market Segmentation by Product Type Geographical Segmentation Get full TOC at: http://www.reportsandintelligence.com/global-insulin-pumps-2014-2018-market/table-of-contents

  4. Questions answered in this report What will the market size be in 2018 and what will the growth rate be? What are key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of each of these key vendors? Get detailed information at: http://www.reportsandintelligence.com/global-orphan-drugs-2014-2018-market

  5. Get access to detailed information at: http://www.reportsandintelligence.com/global-orphan-drugs-2014-2018-market Request for Discount at: http://www.reportsandintelligence.com/purchase-enquiry/17553

More Related